Dr. Lisa Fortier

James Law Professor of Large Animal Surgery
Associate Chair for the Department of Clinical Sciences Committee on Research and Graduate Education

Lisa A. Fortier is the James Law Professor of Surgery and Director or Equine Programs at Cornell University in Ithaca, NY. She received her DVM from Colorado State University and completed her PhD and surgical residency training at Cornell University. She is boarded with the American College of Veterinary Surgeons and practices equine orthopedic surgery at Cornell University in Ithaca, New York and at the Cornell Ruffian Equine Specialists in Elmont, New York. Her laboratory has a particular interest in translational research including the prevention of post-traumatic osteoarthritis. In addition, Lisa’s research program investigates the clinical application of stem cells and biologics such as platelet rich plasma and bone marrow concentrate for cartilage repair and tendinosis. She has received the Jaques Lemans Award from the International Cartilage Repair Society, the New Investigator Research Award from the Orthopaedic Research Society, the Pfizer Research Award for Research Excellence from Cornell University, and the SUNY Chancellors Award for Scholarship and Creative Activites. Lisa has served as the Vice President of the International Veterinary Regenerative Medicine Society, and President of the International Cartilage Repair Society.
 

Perspectives on One-Health Regenerative Medicine

Sunday, September 8, 6:00 PM – 8:00 PM

 
In the spirit of one-medicine, I have been fortunate to foster a program built on a cross-species, cross-discipline, and cross-campus approach toward understanding the etiopathogenesis of, and exploring therapies for, osteoarthritis. On a more global scale, as President of the International Cartilage Repair Society, I sought along with the board and general membership to lay the framework to simultaneously address osteoarthritis in humans and animals through collaborations between academic institutions, private practitioners, industry partners, regulatory agencies, and the leadership of professional societies. This presentation will highlight some of the lessons learned during the course of several successes and failures toward achieving a one-medicine approach to osteoarthritis.

 

 

Amnion-Derived Products – What Are They and How Do They Work?

Tuesday, September 10, 1:30 PM – 2:00 PM

 
There are numerous commercial products available in veterinary and human markets that are based in the use of amnion tissues including amnion +/- chorion or umbilical cord sheets and amnion or cord blood derived cells marketed as stem cell products. We have evaluated eleven different products using proteomics, live/dead confocal staining, and flow cytometry to characterize these products. Results suggest that products do not contain stem cells and very low to no growth factors. These products reportedly have clinical advantages, but their mechanism of action remains unclear.